BERLIN (Reuters) – Switzerland’s COMCO competition commission terminated an investigation against Novartis into possibly using blocking patents, without consequences, it said on Thursday.
COMCO opened the probe in September 2022 to determine whether the pharmaceutical giant intended to unlawfully protect one if its medicines by filing various patent infringement lawsuits, the commission said in a statement.
“The investigation revealed that Novartis’ actions finally were common practice in the field of patent law and, further, did not confirm the above indications of an unlawful restraint of competition,” it said in the statement.
(Reporting by Miranda Murray; Editing by Sonali Paul)
Comments